Local scientific leadership.
Global execution.
Greater clarity at every critical handoff. ChemPartner helps sponsors maintain scientific momentum with a project model built around scientific clarity, transparent delivery planning, and disciplined stewardship of your data and intellectual property.
More clarity for the decisions that matter.
For biotech and pharma innovators, outsourcing discovery and preclinical work is about more than capacity — it is about maintaining control and scientific continuity. ChemPartner bridges discovery and delivery with transparency across where critical work is performed, how data and materials are governed, and how programs stay resilient as requirements evolve.
Project-location visibility
Document anticipated execution locations, contributing scientific functions, delivery teams, and operational dependencies for your key work packages.
Data & access governance
Define how scientific data are generated, stored, accessed, transferred, reviewed, and retained — aligned to each project's requirements and contracts.
Sample & IP stewardship
Set clear expectations for sample custody, permitted use, deliverables, data rights, and intellectual-property ownership from the outset of a program.
Continuity & transition planning
Assess documentation readiness, knowledge- and method-transfer needs, and realistic continuity options before a change becomes urgent.
Built for the reality of modern drug discovery.
Operating from our US-based Boston Center — a translational research, in vivo pharmacology, and DMPK hub — and integrated with our global discovery and development network, we give sponsors the infrastructure and clarity that high-stakes programs demand.
Partnership built on decision-quality data.
Navigating scientific uncertainty takes more than execution — it takes a partner that treats your data and IP with the same rigor as your leadership team, and helps you identify dependencies early.
"For an outsourced program to be truly resilient, scientific quality, operational clarity, and stewardship of sponsor data and intellectual property must be considered together." — Mr. William Woo, CEO, ChemPartner
Operational Governance FAQ
Can all project work be performed at the Boston Center?
Our US-based Boston Center is built for critical scientific leadership and high-visibility execution across translational research, in vivo pharmacology and DMPK. A significant portion of project work can run in Boston, and where scale or specialized modalities are needed we leverage the global network under single-point Boston leadership — always subject to scientific, operational, and contractual feasibility.
How does ChemPartner provide visibility into project delivery?
A transparent project model documents anticipated work packages, contributing functions, delivery teams and location-based dependencies at the outset. Defined milestones, steering reviews and program-aligned data access help you always know where your project stands.
How are sponsor data and materials handled?
Sample custody follows rigorous chain-of-custody protocols, and scientific data are generated, accessed, transferred, reviewed and retained under program-aligned governance defined to each project's requirements and contracts — protecting record integrity and intellectual property.
Can ChemPartner support project transfer or continuity planning?
Where scientifically and operationally feasible, continuity is assessed early — documentation readiness, method-transfer considerations, scientific handover, and transition planning for critical work packages — so realistic options are understood before a change becomes urgent.
